Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Epilepsia 1999;40:792-5
subject to change
And we can think of this program as a temporary bridge to kind of open up and expand access to GLP-1s for obesity in Medicare patients while CMS evaluates what longer-term coverage will look like
Objective: This study assessed the effectiveness, feasibility, acceptability, and potential costeffectiveness of a 12month remote GLP1RAsupported weight management program, comparing outcomes between tirzepatide and semaglutide
R.MenegattiS.HelgesonM
US$ 28.68
US$ 28.91
US$ 27.61
